Frame risk of AZ vax against benefits, urges ATAGI member

Immunologist Associate Professor Margie Danchin has called for 'stronger' communication around the AstraZeneca vaccine to tackle vaccine hesitancy

A member of the group advising the government on COVID-19 vaccines has called for doctors and nurses to provide clearer communication on the benefits and risk of the AstraZeneca vaccine to reduce vaccine hesitancy. 

Immunologist Associate Professor Margie Danchin says it's important for practitioners to frame the risks of having the vaccine against its benefits, especially for people over 50 for whom the vaccine is still recommended.

"That risk benefit equation is the challenge ahead of us in terms of risk communication,” said Professor Danchin, a member of the Australian Technical Advisory Group on Immunisation COVID-19 Working Group.

“We need to be stronger about that. We need to help people interpret those risks.”